Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.
Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS.
Milne RL, et al.
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):350-6. doi: 10.1158/1055-9965.EPI-04-0376.
Cancer Epidemiol Biomarkers Prev. 2005.
PMID: 15734957